0002002665-23-000001.txt : 20231204 0002002665-23-000001.hdr.sgml : 20231204 20231204133813 ACCESSION NUMBER: 0002002665-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231204 DATE AS OF CHANGE: 20231204 EFFECTIVENESS DATE: 20231204 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GelSana Therapeutics, Inc. CENTRAL INDEX KEY: 0002002665 IRS NUMBER: 853369265 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-498739 FILM NUMBER: 231462173 BUSINESS ADDRESS: STREET 1: 12635 E MONTVIEW BLVD STE 216 CITY: AURORA STATE: CO ZIP: 80045 BUSINESS PHONE: (216) 502-0901 MAIL ADDRESS: STREET 1: 12635 E MONTVIEW BLVD STE 216 CITY: AURORA STATE: CO ZIP: 80045 D 1 primary_doc.xml X0708 D LIVE 0002002665 GelSana Therapeutics, Inc. 12635 E MONTVIEW BLVD STE 216 AURORA CO COLORADO 80045 (216) 502-0901 DELAWARE None None Corporation true 2020 Melissa Krebs c/o GelSana Therapeutics, Inc. 12635 E Montview Blvd Ste 216 Aurora CO COLORADO 80045 Executive Officer Director Mike Freeman c/o GelSana Therapeutics, Inc. 12635 E Montview Blvd Ste 216 Aurora CO COLORADO 80045 Director Jim Kasic c/o GelSana Therapeutics, Inc. 12635 E Montview Blvd Ste 216 Aurora CO COLORADO 80045 Director Biotechnology Decline to Disclose 06b false 2023-11-20 false true false 0 3181752 2476750 705002 Total Amount Sold includes $1,681,751.88 of cancellation of convertible promissory notes and $794,994.48 of new cash. false 14 0 0 0 false GelSana Therapeutics, Inc. /s/ Melissa Krebs Melissa Krebs President 2023-11-30